Skip to Main content Skip to Navigation
Journal articles

Negative phase 3 study of Y-90 microspheres versus sorafenib in HCC

Abstract : Correspondence: It is with great interest that we read the report of the SARAH trial by Valérie Vilgrain and colleagues, recently published The Lancet Oncology...
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01709600
Contributor : Laurent Jonchère <>
Submitted on : Thursday, February 15, 2018 - 10:31:03 AM
Last modification on : Friday, October 16, 2020 - 3:31:34 AM

Links full text

Identifiers

Citation

Etienne Garin, Yan Rolland, Boris Campillo-Gimenez, Julien Edeline. Negative phase 3 study of Y-90 microspheres versus sorafenib in HCC. Lancet Oncology, Elsevier, 2018, 19 (2), pp.e69. ⟨10.1016/S1470-2045(18)30025-1⟩. ⟨hal-01709600⟩

Share

Metrics

Record views

128